Official Press Releases
Dr. Link, Dr. Shlain and Mr. Simon all bring deep entrepreneurial experience in the medical and pharmaceutical fields to precision medicine. SAN DIEGO, CA, UNITED STATES, July 21, 2022 /EINPresswire.com/ — CureMatch, Inc., a leader in precision medicine support for oncology, announced today that John S. Link, MD, Jordan Shlain, MD and Greg Simon have […]
CureMatch, Inc., and Alliance Care Technologies International (ACT) have announced a strategic partnership to bring the groundbreaking CureMatch Decision Support System to a greater number of markets, particularly in the MEASA (Middle East, Asian, South Asian) region. This agreement will give more doctors and patients worldwide access to an unprecedented suite of artificial intelligence (AI)-based […]
The Research Consortium announced the release of a new study today that challenges common misconceptions about combination cancer therapies, their cost, and their value. It provides payers, physicians and patients with insight as to how they can avoid wasteful spending on high-cost, low-clinical-value cancer drugs. The concurrent (on- and off-label) use of multiple FDA-approved drugs […]
CureMatch, Inc., a healthcare technology company that leverages artificial intelligence (AI) to power precision medicine support for oncology, announced today that David Szekeres has been named board director. Mr. Szekeres is a seasoned executive with over 20 years in the life sciences industry, with deep operational, commercial, corporate development, strategy, financial, investor relations, and legal […]
CureMatch, Inc., a healthcare technology company that leverages artificial intelligence (AI) to power precision medicine support for oncology, announced today that Dale Brown has been named board director. Mr. Brown is a growth-oriented leader with expertise across healthcare technology, pharmacy benefits, government programs, and consumer services. The founder and CEO of FrictionlessMED, a consultancy that […]